Cargando…

Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression

Detalles Bibliográficos
Autores principales: Ma, Hong-Yu, Li, Yang, Yin, Hui-Zi, Yin, Hang, Qu, Yuan-Yuan, Xu, Qing-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565844/
https://www.ncbi.nlm.nih.gov/pubmed/37829327
http://dx.doi.org/10.1016/j.omtn.2023.102048
_version_ 1785118783677923328
author Ma, Hong-Yu
Li, Yang
Yin, Hui-Zi
Yin, Hang
Qu, Yuan-Yuan
Xu, Qing-Yong
author_facet Ma, Hong-Yu
Li, Yang
Yin, Hui-Zi
Yin, Hang
Qu, Yuan-Yuan
Xu, Qing-Yong
author_sort Ma, Hong-Yu
collection PubMed
description
format Online
Article
Text
id pubmed-10565844
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-105658442023-10-12 Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression Ma, Hong-Yu Li, Yang Yin, Hui-Zi Yin, Hang Qu, Yuan-Yuan Xu, Qing-Yong Mol Ther Nucleic Acids Retraction American Society of Gene & Cell Therapy 2023-10-05 /pmc/articles/PMC10565844/ /pubmed/37829327 http://dx.doi.org/10.1016/j.omtn.2023.102048 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Retraction
Ma, Hong-Yu
Li, Yang
Yin, Hui-Zi
Yin, Hang
Qu, Yuan-Yuan
Xu, Qing-Yong
Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
title Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
title_full Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
title_fullStr Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
title_full_unstemmed Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
title_short Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
title_sort retraction notice to: tnfaip8 promotes cisplatin chemoresistance in triple-negative breast cancer by repressing p53-mediated mir-205-5p expression
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565844/
https://www.ncbi.nlm.nih.gov/pubmed/37829327
http://dx.doi.org/10.1016/j.omtn.2023.102048
work_keys_str_mv AT mahongyu retractionnoticetotnfaip8promotescisplatinchemoresistanceintriplenegativebreastcancerbyrepressingp53mediatedmir2055pexpression
AT liyang retractionnoticetotnfaip8promotescisplatinchemoresistanceintriplenegativebreastcancerbyrepressingp53mediatedmir2055pexpression
AT yinhuizi retractionnoticetotnfaip8promotescisplatinchemoresistanceintriplenegativebreastcancerbyrepressingp53mediatedmir2055pexpression
AT yinhang retractionnoticetotnfaip8promotescisplatinchemoresistanceintriplenegativebreastcancerbyrepressingp53mediatedmir2055pexpression
AT quyuanyuan retractionnoticetotnfaip8promotescisplatinchemoresistanceintriplenegativebreastcancerbyrepressingp53mediatedmir2055pexpression
AT xuqingyong retractionnoticetotnfaip8promotescisplatinchemoresistanceintriplenegativebreastcancerbyrepressingp53mediatedmir2055pexpression